Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where José Paulo Novazzi is active.

Publication


Featured researches published by José Paulo Novazzi.


Arquivos Brasileiros De Cardiologia | 1998

Terapia combinada de colestiramina e inibidores da HMG-CoA redutase na prevenção secundária da doença coronária

José Paulo Novazzi; Leonor do Espírito Santo de Almeida Pinto; Caio Roberto Chimenti Auriemo; Tania Leme da Rocha Martinez

PURPOSE: To evaluate lipid profile changes associated with cholestyramine addition in hypercholesterolemic patients with established coronary heart disease under treatment with HMG-CoA reductase inihibtors that had not achieved the ideal value of LDL-cholesterol. METHODS: Twenty patients with coronary heart disease, (12 submitted to coronary artery bypass grafts, 3 to coronary angioplasty and 5 maintened under clinical management) with mean age of 60.78 years old, who were under hypolipemic diet and were medicated with lovastatin 20mg/d or simvastatin 10mg/d, received cholestyramine, doses ranging from 8 to 16g/day during 8 weeks, aiming to reduce LDL-cholesterol to values less than 100mg/dL. RESULTS: There was a significant reduction of total cholesterol, from initial mean value of 239.52mg/dL to final mean value of 199.00mg/dL, with a mean reduction of 16.92%. The mean value of LDL-cholesterol was also reduced significantly from 172.73mg/dL to 118.26mg/dL, with a mean reduction of 31.53%. Mean triglyceridemia increased, still within the normal reference values, from 145.05mg/dL to 162.00mg/dL, and the mean difference was 11.69%. There was a significant increase of HDL-cholesterol fraction from an initial mean value of 38.00mg/dL to a final mean value of 48.21mg/dL, mean difference of 26.87%. Side effects were not frequent, and did not interfere in the duration of the study. CONCLUSION: The association of cholestyramine to HMG-CoA reductase inihibtors, both in low doses, in patients with primary hypercholesterolemia and high coronary risk is a good therapeutic option that can reach benefits on the lipid profile similar to those obtained when these drugs are used in association or separately in higher doses.


Arquivos Brasileiros De Cardiologia | 2007

IV Diretriz Brasileira sobre Dislipidemias e Prevenção da Aterosclerose: Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia

Andrei C. Sposito; Bruno Caramelli; Francisco Antonio Helfenstein Fonseca; Marcelo Chiara Bertolami; Abrahão Afiune Neto; Aguinaldo David Souza; Ana Maria Pitta Lottenberg; Ana Paula Marte Chacra; André Arpad Faludi; Andréia Assis Loures-Vale; Antonio Carlos Carvalho; Bruce Bartholow Duncan; Bruno Gelonese; Carisi Anne Polanczyk; Carlos Roberto Martins Rodrigues Sobrinho; Carlos Scherr; Cynthia Karla; Dikran Armaganijan; Emílio Hideyuki Moriguchi; Saraiva Fk; Geraldo Pichetti; Hermes Toros Xavier; Hilton Chaves; Jairo Lins Borges; Jayme Diament; Jorge Ilha Guimarães; José Carlos Nicolau; José Ernesto dos Santos; José Jayme Galvão de Lima; José Luiz da Costa Vieira


Arquivos Brasileiros De Cardiologia | 2007

[IV Brazilian Guideline for Dyslipidemia and Atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology].

Andrei C. Sposito; Bruno Caramelli; Francisco Antonio Helfenstein Fonseca; Marcelo Chiara Bertolami; Afiune Neto A; Souza Ad; Lottenberg Am; Ana Paula Marte Chacra; André Arpad Faludi; Andréia Assis Loures-Vale; Antonio Carlos Carvalho; Bruce Bartholow Duncan; Gelonese B; Carisi Anne Polanczyk; Rodrigues Sobrinho Cr; Carlos Scherr; Karla C; Dikran Armaganijan; Emílio Hideyuki Moriguchi; Saraiva Fk; Pichetti G; Hermes Toros Xavier; Hilton Chaves; Jairo Lins Borges; Jayme Diament; Jorge Ilha Guimarães; José Carlos Nicolau; dos Santos Je; de Lima Jj; José Luiz da Costa Vieira


Atherosclerosis | 2009

Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes: the genetics, outcomes, and lipids in type 2 diabetes (GOLD) study.

Maria Cristina de Oliveira Izar; Tatiana Helfenstein; Silvia Saiuli Miki Ihara; Waldir Gabriel Miranda Relvas; Ao Santos; S. Fischer; Leonor E. Pinto; Ieda Edite Lanzarini Lopes; Daniel Roberto Pomaro; Marília Izar Helfenstein Fonseca; Luis Carlos Bodanese; Emílio Hideyuki Moriguchi; José Francisco Kerr Saraiva; Luiz Introcaso; Agnaldo D. Souza; Marileia Scartezini; Kerginaldo Paulo Torres; Leao Zagury; Paulo César Brandão Veiga Jardim; Eduardo A. S. Costa; Lucia H. Tacito; Adriana Costa e Forti; Maria Eliane Campos Magalhães; Antonio Roberto Chacra; Marcelo Chiara Bertolami; Andréia Assis Loures-Vale; Marco Antonio de Barros; Hermes Toros Xavier; Ruy Lyra; Dikran Argamanijan


Arquivos Brasileiros De Cardiologia | 2006

Efeitos do exercício agudo na lipemia pós-prandial em homens sedentários

Mônica Teixeira; Nelson Kasinski; Maria Cristina de Oliveira Izar; Luiz Alberto Barbosa; José Paulo Novazzi; Leonor do Espírito Santo de Almeida Pinto; Sergio Tufik; Turíbio Ferreira Leite; Francisco Antonio Helfenstein Fonseca


Rev. Soc. Cardiol. Estado de Säo Paulo | 1996

Obesidade e coraçäo

Tania Leme da Rocha Martinez; José Paulo Novazzi; Andréia Assis Louro Vale; Paulo Fernando Leite


Archive | 1996

Tratamento das dislipidemias

José Paulo Novazzi; Tania Leme da Rocha Martinez; Francisco Antonio Helfenstein Fonseca; Maysa Seabra Cendoroglo; Sociedade de Cardiologia do Estado de Säo Paulo


Arquivos Brasileiros De Cardiologia | 1996

Avaliação da eficácia e segurança do etofibrato em pacientes dislipidêmicos. Estudo multicêntrico

José Ernesto dos Santos; Andréia Assis Loures-Vale; José Paulo Novazzi; Lisia Marcilio Rabelo; Tania Leme da Rocha Martinez


Archive | 1994

Diagnóstico das dislipidemias

Francisco Antonio Helfenstein Fonseca; José Paulo Novazzi; Tania Leme da Rocha Martinez; Sociedade de Cardiologia do Estado de Säo Paulo


Atherosclerosis Supplements | 2007

D 002 IMPACT OF METABOLIC SYNDROME AND MYOCARDIAL INFARCTION ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES

Vs Pereira; T Rodgério; Wgm Relvas; Ldesa Pinto; S.S.M. Ihara; T Helfenstein; Rms Póvoa; José Paulo Novazzi; Nelson Kasinski; Acc Carvalho; Fah Fonseca; Mco Izar

Collaboration


Dive into the José Paulo Novazzi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andréia Assis Loures-Vale

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar

Maria Cristina de Oliveira Izar

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

Marcelo Chiara Bertolami

University of Santiago de Compostela

View shared research outputs
Top Co-Authors

Avatar

Emílio Hideyuki Moriguchi

Pontifícia Universidade Católica do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mônica Teixeira

Federal University of São Paulo

View shared research outputs
Top Co-Authors

Avatar

Nelson Kasinski

Federal University of São Paulo

View shared research outputs
Researchain Logo
Decentralizing Knowledge